Gadsden Properties (OTCMKTS:GADS) vs. electroCore (NASDAQ:ECOR) Critical Contrast

Gadsden Properties (OTCMKTS:GADS) and electroCore (NASDAQ:ECOR) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Valuation and Earnings

This table compares Gadsden Properties and electroCore”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gadsden Properties	N/A	N/A	N/A	N/A	N/A
electroCore	$23.33 million	3.67	-$18.83 million	($1.83)	-7.03

Gadsden Properties has higher earnings, but lower revenue than electroCore.

Volatility and Risk

Gadsden Properties has a beta of -5.57, suggesting that its stock price is 657% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500.

Institutional & Insider Ownership

26.7% of electroCore shares are held by institutional investors. 5.0% of Gadsden Properties shares are held by insiders. Comparatively, 19.7% of electroCore shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Gadsden Properties and electroCore’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gadsden Properties	N/A	N/A	N/A
electroCore	-54.40%	-154.45%	-69.16%

Analyst Ratings

This is a summary of recent ratings and target prices for Gadsden Properties and electroCore, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gadsden Properties	0	0	0	0	0.00
electroCore	0	0	1	0	3.00

electroCore has a consensus target price of $25.00, indicating a potential upside of 94.40%. Given electroCore’s stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Gadsden Properties.

Summary

electroCore beats Gadsden Properties on 7 of the 10 factors compared between the two stocks.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

About electroCore

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.